Prevention & lipids

Cardiovascular Morbidity and Functional Dependency in an Ageing Europe: EU27 Projections to 2050

Eur Heart J Qual Care Clin OutcomesPublished prevalence-based macrosimulation

Authors' conclusion

Severe ADL dependency could increase faster than the older cardiovascular population, but sustained functional improvements could reverse this trajectory. Cardiovascular care planning should account for both population growth and changing functional health.

Study context

Population
Older adults (aged ≥65 years) with cardiovascular disease across the EU27
Outcome
Population aged ≥65 years with CVD
Follow-up
2021 to 2050
Methodological detailsdecomposition and sensitivity analyses, uncertainty propagation was incomplete
  • Decomposition and sensitivity analyses
  • Uncertainty propagation was incomplete

Main finding

As reported in the abstract

Projected increase from 44.1 to 59.2 million

+34.3%

Further findings

Modelled co-occurrence of cardiovascular disease (CVD) with severe activities of daily living (ADL) dependency (not dependency attributable to CVD) · 2021 to 2050

Increase from 4.06 to 6.21 million
+53.0%
Proportion raised from 9.2% to 10.5%

Drivers of the increase in number

Demographic change drove the increase in number, partly offset by declining CVD prevalence

Annual relative ADL declines needed to stabilise the proportion and number

Stabilise the proportion
0.45%
Stabilise the number
1.46%
  • Under reference assumptions

Co-occurrence of CVD with severe ADL dependency under continuation of EHIS declines

Number reduced to 3.61 million
−11.1%
Proportion reduced to
6.1%
  • Post hoc
  • Fixed country and sex weights under the same CVD trajectory

Original publication

Cardiovascular Morbidity and Functional Dependency in an Ageing Europe: EU27 Projections to 2050. Eur Heart J Qual Care Clin Outcomes. Published 6 November 2026. doi:10.1093/ehjqcco/qcag160

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.